Search

Your search keyword '"Moysich, KB"' showing total 191 results

Search Constraints

Start Over You searched for: Author "Moysich, KB" Remove constraint Author: "Moysich, KB" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
191 results on '"Moysich, KB"'

Search Results

1. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

2. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk

3. Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis

4. High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival

5. Polygenic risk modeling for prediction of epithelial ovarian cancer risk (vol 30, pg 349, 2021)

6. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

7. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci

8. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium

9. Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers

10. Shared heritability and functional enrichment across six solid cancers

11. Shared heritability and functional enrichment across six solid cancers (vol 10, 431, 2019)

12. A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk

13. Adult height is associated with increased risk of ovarian cancer: A Mendelian randomisation study

14. Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study

15. Adult height is associated with increased risk of ovarian cancer: A Mendelian randomisation study

16. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

17. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer

18. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology

19. History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium

20. Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium

21. Use of common analgesic medications and ovarian cancer survival: Results from a pooled analysis in the Ovarian Cancer Association Consortium

22. History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report.

23. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci

24. Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study

25. Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers

26. Adult body mass index and risk of ovarian cancer by subtype: A Mendelian randomization study

27. Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium.

28. A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer

29. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

30. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

31. A targeted genetic association study of epithelial ovarian cancer susceptibility.

32. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

33. Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk

34. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

35. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC).

36. Identification of six new susceptibility loci for invasive epithelial ovarian cancer

37. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

38. Genome-wide significant risk associations for mucinous ovarian carcinoma

39. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer

40. Common genetic variation in cellular transport genes and epithelial ovarian cancer (EOC) risk

41. Understanding risk factors for endometrial cancer in young women.

42. T Cell Exhaustion Markers in Multiple Myeloma Patients are Lower After Physical Activity Intervention.

43. Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.

44. Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2).

45. Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease.

46. Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.

47. Dietary risk factors for monoclonal gammopathy of undetermined significance in a racially diverse population.

48. A framework for assessing interactions for risk stratification models: the example of ovarian cancer.

49. Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.

50. Risk prediction models for endometrial cancer: development and validation in an international consortium.

Catalog

Books, media, physical & digital resources